The impact of COVID-19 on elective and urgent digestive endoscopic procedures: a report on a year of pandemic in a gastroenterology centre in Italy.
COVID-19
SARS-CoV-2
colonoscopy
endoscopic ultrasound
endoscopic-retrograde-cholangio-pancreatography
esophagogastroduodenoscopy
fine-needle aspiration
Journal
Przeglad gastroenterologiczny
ISSN: 1895-5770
Titre abrégé: Prz Gastroenterol
Pays: Poland
ID NLM: 101280380
Informations de publication
Date de publication:
2022
2022
Historique:
received:
10
06
2021
accepted:
03
11
2021
entrez:
14
12
2022
pubmed:
15
12
2022
medline:
15
12
2022
Statut:
ppublish
Résumé
The COVID-19 pandemic (COVID-19) affected digestive endoscopic activity worldwide. Resumption and maintenance of elective endoscopic activity are crucial to containing the impact of COVID-19 on mortality and prognosis of gastrointestinal disorders, primarily cancers. To assess the impact of COVID-19 during and after the lockdown period on endoscopic activity. The endoscopic activity undertaken during the COVID-19-related lockdown (March 2020-May 2020) and in the post-lockdown period (June 2020-March 2021) was compared with that in the corresponding periods of the year before COVID-19 in a gastroenterology centre in Italy. During the lockdown period, there was a reduction in esophagogastroduodenoscopy (EGD), colonoscopy (CSPY), endoscopic ultrasound (EUS), and endoscopic-retrograde cholangiopancreatography (ERCP) of 75.8%, 74.8%, 60%, and 42%, respectively, compared with the corresponding period of the year before COVID-19. During the post-lockdown period to date, EGD, CSPY, EUS, and ERCP increased as compared to the lockdown period (30.6%, 50.6%, 33.6%, and 65.4%, respectively), but only ERCP showed a full recovery when compared with the corresponding period of the year before COVID-19. Endoscopic activity decreased significantly during the COVID-19 lockdown, and only ERCP had a full recovery in the post-lockdown period. The pandemic-related limitations and the backlog of endoscopic procedures represent important reasons for the increased risk or delayed diagnosis of GI cancers.
Identifiants
pubmed: 36514451
doi: 10.5114/pg.2021.111392
pii: 45773
pmc: PMC9743327
doi:
Types de publication
Journal Article
Langues
eng
Pagination
301-309Informations de copyright
Copyright © 2022 Termedia.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Frontline Gastroenterol. 2019 Apr;10(2):141-147
pubmed: 31205654
Gut. 2021 Mar;70(3):537-543
pubmed: 32690602
Dig Liver Dis. 2021 Jun;53(6):682-688
pubmed: 33726978
Gastroenterology. 2020 Jul;159(1):363-366.e3
pubmed: 32283102
Lancet Oncol. 2020 Aug;21(8):1023-1034
pubmed: 32702310
Endoscopy. 2020 Dec;52(12):1111-1115
pubmed: 32557489
Gastrointest Endosc. 2018 Feb;87(2):327-337
pubmed: 29306520
Gastroenterology. 2020 Sep;159(3):1164-1166.e3
pubmed: 32425228
Dig Liver Dis. 2021 Jan;53(1):1-3
pubmed: 33268267
Intern Emerg Med. 2021 Aug;16(5):1197-1206
pubmed: 33555540
Lancet Oncol. 2020 Jun;21(6):750-751
pubmed: 32359403
Endosc Int Open. 2021 Apr;9(4):E543-E551
pubmed: 33816775
Int J Colorectal Dis. 2020 Oct;35(10):1951-1954
pubmed: 32500432
Lancet Oncol. 2020 Aug;21(8):1035-1044
pubmed: 32702311
Endoscopy. 2020 Jun;52(6):483-490
pubmed: 32303090
Dig Liver Dis. 2020 Aug;52(8):808-815
pubmed: 32425733
Endoscopy. 2020 Oct;52(10):891-898
pubmed: 32643767
Endoscopy. 2019 Mar;51(3):266-277
pubmed: 30722071
Scand J Gastroenterol. 2020 Jul;55(7):870-876
pubmed: 32615891
Endoscopy. 2020 Nov;52(11):1036-1038
pubmed: 32408356
Nat Rev Gastroenterol Hepatol. 2020 Aug;17(8):444-446
pubmed: 32405033
Endoscopy. 2020 Aug;52(8):687-700
pubmed: 32572858
Health Care Manage Rev. 2011 Oct-Dec;36(4):327-37
pubmed: 21697719
Eur J Public Health. 2012 Oct;22(5):629-33
pubmed: 22037593
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631
Soc Sci Med. 2015 May;132:113-21
pubmed: 25795994
BMC Gastroenterol. 2021 Jan 7;21(1):22
pubmed: 33413147